J2 Ventures, BonAngels Venture Partners and a diverse group of angel investors backed the company through the seed funding. Stat Health also received grant funding from the U.S. Air Force.
Boston-based Stat Health designed its wearable to help understand symptoms like dizziness, brain fog, headaches, fainting and fatigue upon standing. These common symptoms can indicate illnesses like long COVID and postural orthostatic tachycardia syndrome (POTS). They also may signal myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS), and other orthostatic syndromes.
According to Stat Health, reduced blood flow to the brain upon standing causes the symptoms for these illnesses.
The company clinically tested its offering at Johns Hopkins and it was peer-reviewed in th…